References
- SalgadoRDenkertCDemariaSThe evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014Ann Oncol20142625927125214542
- IbrahimEMAl-FoheidiMEAl-MansourMMKazkazGAThe prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysisBreast Cancer Res Treat2014148346747625361613
- DenkertCvon MinckwitzGBraseJCTumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancersJ Clin Oncol20153398399125534375
- MittendorfEACliftonGTHolmesJPFinal report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patientsAnn Oncol20142591735174224907636
- LadjemiMZChardesTCorgnacSVaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) miceBreast Cancer Res2011131R1721294885
- PalSSahaAMohantyKGeneration of Her-2/neu vaccine utilizing idiotypic network cascadeCancer Biol Ther20076121916192518059165
- DranoffGJaffeeELazenbyAVaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunityProc Natl Acad Sci U S A1993908353935438097319
- EagerRNemunaitisJGM-CSF gene-transduced tumor vaccinesMol Ther2005121182715963916
- BorrelloISotomayorEMCookeSLevitskyHIA universal granulocyte-macrophage colony-stimulating factor-producing bystander cell line for use in the formulation of autologous tumor cell-based vaccinesHum Gene Ther199910121983199110466632
- DessureaultSAlsarrajMMcCarthySA GM-CSF/CD40L producing cell augments anti-tumor T cell responsesJ Surg Res2005125217318115854671
- KleinABWitonskySGAhmedSAImpact of different cell isolation techniques on lymphocyte viability and functionJ Immunoassay Immunochem2006271617616450869
- EwensAMihichEEhrkeMJDistant metastasis from subcutaneously grown E0771 medullary breast adenocarcinomaAnticancer Res2005256B3905391516312045
- ChiodoniCPagliaPStoppacciaroARodolfoMParenzaMColomboMPDendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte responseJ Exp Med1999190112513310429676
- LiXOryVChapmanSROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cellsAm J Pathol2012180259960722189618
- DessureaultSNoyesDLeeDA phase-I trial using a universal GM-CSF-producing and CD40L-expressing bystander cell line (GM.CD40L) in the formulation of autologous tumor cell-based vaccines for cancer patients with stage IV diseaseAnn Surg Oncol200714286988417103257
- GrayJEChiapporiAWilliamsCCA phase I/II randomized trial using GM-CSF-producing and CD40L-expressing bystander cell line (GM.CD40L) vaccine in combination with CCL21 in stage IV lung adenocarcinoma: preliminary resultsJ Clin Oncol20133115 abstr 3091
- CreelanBCAntoniaSNoyesDPhase II trial of a GM-CSF-producing and CD40L-expressing bystander cell line combined with an allogeneic tumor cell-based vaccine for refractory lung adenocarcinomaJ Immunother201336844245023994887